J. Joseph Kim

J. Joseph Kim
  • President and Chief Executive Officer
    Inovio Pharmaceuticals

BSc, MIT; MBA, Wharton School; PhD, University of Pennsylvania. Formerly, vaccine developer, Merck & Co. Editor and Board Member, Biotechnology Letters. Author of over 100 peer-reviewed scientific papers. Recipient of awards: TR100 Top 100 Innovators; Technology Review Award; 40 Under 40 Award, Philadelphia Business Journal; 50 Most Influential Men Under 38, Details Magazine.